Allegro Investment Fund
VC Fund
Heverlee, Belgium
Allegro Investment Fund is an open end seed capital investment fund, focussing on high-tech ventures. With a combined experience of more then 40 years of experience in high-tech start-up management, the AIF team adds smart money to your capital needs.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Allegro Investment Fund invests in
Stages Allegro Investment Fund invests in
Countries Allegro Investment Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.9M–$6.9M
- Series B
- $10M–$19M
Investment Focus
Industry
- Software 3 (27%)
- Hardware 2 (18%)
- Health Care 2 (18%)
- Apps 1 (9%)
- Mobile 1 (9%)
Stage
- Series A 3 (27%)
- Funding Round 3 (27%)
- Series B 2 (18%)
- Series C 2 (18%)
Country
- Belgium 5 (45%)
- United States 2 (18%)
- The Netherlands 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Staffan Encrantz
Chairman
|
Chairman | Total investments: 2 | Find email | |
Alex Van den Bossche
Co-Founder
|
Co-Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to addressthe underlying physiology of ophthalmic disease.The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.It was founded in 2011 and is headquartered in Menlo Park, California, United States. | $10M / Series C / Oct 09, 2017 | ||
| Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease. Sight Sciences' devices and non-invasive dry eye products are used for glaucoma procedures or in combination with cataract surgery using the same clear corneal incision, assisting ophthalmologists and optometrists to addressthe underlying physiology of ophthalmic disease.The company's non-surgical Dry Eye product portfolio consists of TearCare which is now commercially available for both ophthalmologists and optometrists. TearCare is a software-controlled, wearable eyelid technology that delivers highly targeted and adjustable heat to the meibomian glands of the eyelids for conditions such as meibomian gland dysfunction and dry eye.It was founded in 2011 and is headquartered in Menlo Park, California, United States. | $6.9M / Series A / Oct 30, 2015 | ||
| Mass Relevance develops and offers cloud-based software for media and entertainment sectors.Its software enables social media content aggregation, filtration, and integration. The company's clientele includes December, 2010. The company was founded in 2009 and is based in Austin, Texas.In April 2014, Mass Relevance merged with Spredfast, forming a comprehensive social marketing company. | $3.3M / Series A / May 16, 2012 | ||
| GreenPeak Technologies operates as a fabless semiconductor and is one of the leaders in the ZigBee market with a rich offering of RF chips for the Smart Home and the IoT.Driven by the world’s MSOs, GreenPeak is proving its market leadership position as the Internet of Things connectivity technology provider for the Smart Home.GreenPeakTechnologies is a fabless semiconductor company and the leader in the ZigBee market with a rich offering of semiconductor products and software technologies for Smart Home data communications and the Internet of Things.The GreenPeak founders have significantly contributed to the invention of WiFi and made it into a commercial success, used by several billion people today. GreenPeak is recognised as a leader in developing new wireless technologies for consumer electronics, Smart Home applications and the IoT/IoE, demonstrating rapid growth and adoption by major customers around the globe.It offers its products for original equipment manufacturers in the United States, Europe, and Asia. The company was formerly known as Xanadu Wireless and changed its name to GreenPeak Technologies B.V. in 2007. GreenPeak Technologies was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, Japan, France, California, US as well as in Korea and Hong Kong. | $19M / Series B / Oct 29, 2009 | ||
| Visys NV, The optical sorting innovation Company, is a leading state-of-the-art provider of Digital automated sorting solutions to the global food and non-food processing industry. | $1.8M / Series C / Jun 30, 2008 | ||
| iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for thebusiness-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium | $3.2M / Mar 06, 2008 | ||
| Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting. | $1.9M / Nov 08, 2007 | ||
| iNEWiT, an engineering company, engages in identifying, designing, and creating applications and devices for the mobile market. It provides mobile video communication applications; wireless communication technologies, ranging from GPRS/EDGE, over 3G, HSDPA/HSUPA to WiFi, and WiMAX and satellite networks; and plug and play products for thebusiness-to-consumer markets. The company was founded in 2005 and is based in Mechelen, Belgium | $1.9M / Series A / Feb 28, 2007 | ||
| Quick Sensor N.V. offers seat control and detection system that provides overview of the audience behavior with the use of sensors embedded in movie theatre seating. Its system enables seat detection, as well as gathers and stores the seating information for retrieval and processing. Quick Sensor N.V. was founded in 2004 and is headquartered inIzegem, Belgium. | $1.3M / Feb 13, 2007 | ||
| AsicAhead NV operates as a fabless semiconductor products manufacturing company. It develops integrated circuits for mobile, wireless and wire-line communications. The company offers radio frequency silicon solutions, including zero-IF radio architectures, on chip analog tunable filtering, transmitter loops, fully integrated synthesizers, analogdigital converter, and digital analog converters. It offers wireless analog and mixed-signal integrated circuits for wireless applications in global system for mobile communication, wireless local area network, bluetooth, and ultra wide band. AsicAhead was founded in 2003 and is headquartered in Genk, Belgium. The company also has offices in Mountain View, California and Godalming, the United Kingdom. As of August 31, 2008, AsicAhead NV operates as a subsidiary of AnSem N.V.. | $10M / Series B / Jan 09, 2007 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Allegro Investment Fund invest in?
Allegro Investment Fund invests primarily in Software, Hardware and Health Care startups, most often at Series A and Funding Round stage. Most of the 11 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Allegro Investment Fund's check size?
Allegro Investment Fund typically joins rounds of $1.9M–$6.9M at Series A and $10M–$19M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Allegro Investment Fund participates in.
How do I contact Allegro Investment Fund?
Public channels for Allegro Investment Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Allegro Investment Fund?
The team at Allegro Investment Fund includes Staffan Encrantz (Chairman) and Alex Van den Bossche (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
